Crucial Updates: FDA Bolsters Adverse Event Monitoring for Enhanced Public Safety
Alarm Bells Ring as Valneva's Groundbreaking Chikungunya Vaccine, IXCHIQ, Faces U.S. Suspension Over Safety Fears